171 related articles for article (PubMed ID: 2785520)
1. The occurrence of epidermal growth factor receptors and the characterization of EGF-like factors in human ovarian, endometrial, cervical and breast cancer. EGF receptors and factors in gynecological carcinomas.
Bauknecht T; Kohler M; Janz I; Pfleiderer A
J Cancer Res Clin Oncol; 1989; 115(2):193-9. PubMed ID: 2785520
[TBL] [Abstract][Full Text] [Related]
2. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
[TBL] [Abstract][Full Text] [Related]
3. Human ovarian carcinomas: correlation of malignancy and survival with the expression of epidermal growth factor receptors (EGF-R) and EGF-like factors (EGF-F).
Bauknecht T; Janz I; Kohler M; Pfleiderer A
Med Oncol Tumor Pharmacother; 1989; 6(2):121-7. PubMed ID: 2787460
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of oncogenes and growth factors in ovarian carcinomas.
Bauknecht T; Birmelin G; Kommoss F
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):855-62. PubMed ID: 2285597
[TBL] [Abstract][Full Text] [Related]
5. Characterization of growth factors in human ovarian carcinomas.
Bauknecht T; Kiechle M; Bauer G; Siebers JW
Cancer Res; 1986 May; 46(5):2614-8. PubMed ID: 3008995
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor and transforming growth factor alpha mRNA expression in human breast cancer biopsies; analysis in relation to estradiol, progesterone and EGF receptor content.
Artagaveytia N; Le Penven S; Falette N; Lucero R; Garófalo EG; Saez S
J Steroid Biochem Mol Biol; 1997 Feb; 60(3-4):221-8. PubMed ID: 9191980
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor-like activity and epidermal growth factor-receptors in human primary breast cancer.
Kahán Z; Szücs M; Vecsernyés M; Eckhardt S
Breast Cancer Res Treat; 1993; 26(1):41-7. PubMed ID: 8400322
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical studies on epidermal growth factor receptor (EGF-R) in gynecological malignant tumor].
Furugen Y
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Apr; 43(4):410-6. PubMed ID: 2066613
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-1-R) and somatostatin (SS-R) in patients with breast and ovarian cancer.
Foekens JA; van Putten WL; Portengen H; Rodenburg CJ; Reubi JC; Berns PM; Henzen-Logmans SC; van der Burg ME; Alexieva-Figusch J; Klijn JG
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):815-21. PubMed ID: 2178364
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer.
Foekens JA; Portengen H; Janssen M; Klijn JG
Cancer; 1989 Jun; 63(11):2139-47. PubMed ID: 2541884
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor in human breast cancer, endometrial carcinoma and lung cancer. Its relationship to epidermal growth factor receptor, estradiol receptor and tumor TNM.
Bolufer P; Lluch A; Molina R; Alberola V; Vazquez C; Padilla J; Garcia-Conde J; Llopis F; Guillem V
Clin Chim Acta; 1993 Apr; 215(1):51-61. PubMed ID: 8513568
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptors in human breast and endometrial carcinomas.
Llorens MA; Bermejo MJ; Salcedo MC; Charro AL; Puente M
J Steroid Biochem; 1989; 34(1-6):505-9. PubMed ID: 2626045
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of growth factors in patients with ovarian cancer.
Feldkämper M; Enderle-Schmitt U; Hackenberg R; Schulz KD
Eur J Cancer; 1994; 30A(12):1851-8. PubMed ID: 7880617
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analyses of epidermal growth factor receptors, HER-2/neu oncoprotein and cathepsin D in nonmalignant and malignant uteri.
Sanfilippo JS; Miseljic S; Yang AR; Doering DL; Shaheen RM; Wittliff JL
Cancer; 1996 Feb; 77(4):710-6. PubMed ID: 8616763
[TBL] [Abstract][Full Text] [Related]
15. mRNA expression of ligands of the epidermal-growth-factor-receptor in the uterus.
Pfeiffer D; Spranger J; Al-Deiri M; Kimmig R; Fisseler-Eckhoff A; Scheidel P; Schatz H; Jensen A; Pfeiffer A
Int J Cancer; 1997 Aug; 72(4):581-6. PubMed ID: 9259394
[TBL] [Abstract][Full Text] [Related]
16. Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas.
Gullick WJ; Marsden JJ; Whittle N; Ward B; Bobrow L; Waterfield MD
Cancer Res; 1986 Jan; 46(1):285-92. PubMed ID: 2998607
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor reduces HER-2 protein level in human ovarian carcinoma cells.
Marth C; Lang T; Cronauer MV; Doppler W; Zeimet AG; Bachmair F; Ullrich A; Daxenbichler G
Int J Cancer; 1992 Sep; 52(2):311-6. PubMed ID: 1355758
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
[TBL] [Abstract][Full Text] [Related]
19. [Detection of epidermal growth factor-like factors in various skin tumors].
Hagedorn M; Bauknecht T
Z Hautkr; 1990 Jun; 65(6):575-7. PubMed ID: 2389591
[TBL] [Abstract][Full Text] [Related]
20. Gene structure and expression analysis of the epidermal growth factor receptor, transforming growth factor-alpha, myc, jun, and metallothionein in human ovarian carcinomas. Classification of malignant phenotypes.
Bauknecht T; Angel P; Kohler M; Kommoss F; Birmelin G; Pfleiderer A; Wagner E
Cancer; 1993 Jan; 71(2):419-29. PubMed ID: 8422634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
